Howard G. Hutchinson

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Diabetes, Cardiovascular Risks, and Lipoproteins, Blood Pressure and Hypertension Studies

Most-Cited Works

• → The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.(1995)678 cited
• → Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.(1994)238 cited
• → Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia(2002)231 cited
• → AT₁and AT₂Angiotensin Receptor Gene Expression in Human Heart Failure(1997)183 cited
• → Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial(2002)158 cited
• → Lisinopril Versus Hydrochlorothiazide in Obese Hypertensive Patients(1997)155 cited
• → Rosuvastatin-Induced Arrest in Progression of Renal Disease(2004)153 cited
• → Safety of rosuvastatin(2004)133 cited
• → Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues(1999)128 cited
• → Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.(1993)117 cited